Inscripta plans to expand the capabilities of its Onyx™ Digital Genome Engineering platform beyond microbes, to include the ability to support mammalian cells including humans, CEO Kevin Ness tells GEN Edge.
The assay is heat stable at ambient or elevated temperatures, bypassing the need for cold chain during transport and storage.
One of the world’s largest protein datasets offers new insights into the biological underpinnings of major neurodegenerative diseases.
The compatibility of technologies is critical to the commercialization of advanced therapies in the biotechnology industry.
In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned from designing, validating, and scaling potency…
Researchers show that a brain protein, termed cypin, modulates protein ubiquitination to regulate synaptic plasticity in neurons.
The potential of gene therapies will only be realized if the manufacturing challenges can be resolved, and that’s a tricky task.
Study in rats indicates amyloid-beta and tau amyloids are “just the tip of the iceberg.”
A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.
In this GEN webinar, Dave Lahr, PhD, Senior Director of Bioinformatics at Foghorn Therapeutics, discusses chromatin regulation and epigenetic mechanisms that shape transcriptional responses to…
On this GEN Live, we take a close look at the work behind this successful treatment and perhaps more importantly, we explore how this can…
